Parkinson's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People diagnosed with idiopathic Parkinson's disease (the most common form, with no known external cause), confirmed using a standard set of medical criteria used in the UK.
- People whose Parkinson's disease falls within stages 2 to 4 on a standard scale used to measure how the condition affects movement and daily life.
- People who have been on a stable, unchanged dose of their Parkinson's disease medications for at least 4 weeks before the initial screening appointment.
- People between the ages of 40 and 85 years old.
- People who are able to understand the study and give their own informed consent to participate.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose Parkinson's disease is classified as an atypical or secondary form (meaning it is caused by another condition or has features beyond typical Parkinson's disease).
- People who have a fistula or narrowing in the oesophagus (the tube connecting the throat to the stomach) where the narrowed opening is smaller than the capsule used in the trial.
- People who have had part of their intestine surgically removed within the last six months.
- People who have previously had surgery on the stomach, oesophagus, or the throat and mouth area.
- People who are unable to swallow capsules.
- People who are pregnant, as confirmed by the information provided by the participant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of OCT TCE to identify Parkinson's Disease based on image adequacy; Feasibility of OCT TCE to identify Parkinson's Disease based on morphological changes compared to matched controls
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.